LH
Labcorp insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$308.65
+13.4% over 12 months
Share price and insider trades
LH closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$13.7M
Insiders buying0
Insiders selling10
Valuation, profit and volume
P/E (trailing)25.5Sector median 24.5
Market value$25.03BDiagnostics & Research
Profit margin7.0%Revenue growth +5.8%
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Labcorp insiders reported open-market purchases totaling $0, while 10 insiders reported sales totaling $13.7M. 14 of 21 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 129 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 18SEC | Kerrii B AndersonDirector | Sell Plan | 3,000 | $318.02 | $954K | -2.9% | — |
| Aug 12SEC | Adam H SchechterCEO, President | Sell Plan | 4,669 | $320.37 | $1.5M | -3.7% | — |
| Aug 6SEC | Amy B. SummyEvp, Chief Marketing Officer | Sell | 924 | $306.74 | $283K | +0.6% | — |
| Aug 5SEC | Peter J WilkinsonSvp, Chief Accounting Officer | Sell | 1,338 | $309.23 | $414K | -0.2% | — |
| Aug 5SEC | Peter J WilkinsonSvp, Chief Accounting Officer | Sell | 82 | $309.22 | $25K | -0.2% | — |
| Jul 6SEC | Bryan T VaughnPresident | Sell Plan | 234 | $286.19 | $67K | +7.8% | — |
| Jul 6SEC | Kathryn W KyleGeneral Counsel | Sell Plan | 92 | $286.19 | $26K | +7.8% | — |
| Jun 10SEC | Kathryn W KyleGeneral Counsel | Sell Plan | 762 | $263.89 | $201K | +17.0% | — |
| May 13SEC | Adam H SchechterCEO, President | Sell Plan | 5,903 | $254.50 | $1.5M | +21.3% | — |
| Mar 30SEC | Peter J WilkinsonSvp, Chief Accounting Officer | Sell Plan | 1,633 | $267.05 | $436K | +15.6% | — |
| Mar 30SEC | Jonathan C MeltzerEvp, Operations | Sell Plan | 839 | $267.05 | $224K | +15.6% | — |
| Mar 5SEC | Adam H SchechterCEO, President | Sell | 8,705 | $279.96 | $2.4M | +10.2% | — |
| Mar 3SEC | Der Vaart Sandra D VanEvp, Corporate Affairs | Sell | 548 | $284.91 | $156K | +8.3% | — |
| Feb 26SEC | Brian J CaveneyEvp, Pres Of Ed, Cmo & Cso | Sell | 1,500 | $286.31 | $429K | +7.8% | — |
| Feb 23SEC | Peter J WilkinsonSvp, Chief Accounting Officer | Sell Plan | 666 | $277.94 | $185K | +11.0% | — |
| Feb 13SEC | Adam H SchechterCEO, President | Sell Plan | 5,273 | $284.38 | $1.5M | +8.5% | — |
| Feb 13SEC | Jonathan C MeltzerEvp, Operations | Sell Plan | 87 | $290.42 | $25K | +6.3% | — |
| Feb 12SEC | Jonathan C MeltzerEvp, Operations | Sell Plan | 91 | $276.79 | $25K | +11.5% | — |
| Feb 10SEC | Jonathan C MeltzerEvp, Operations | Sell Plan | 88 | $275.53 | $24K | +12.0% | — |
| Nov 13SEC | Adam H SchechterCEO, President | Sell Plan | 5,745 | $262.75 | $1.5M | +17.5% | — |
| Nov 4SEC | Richelle P ParhamDirector | Sell | 7,009 | $254.28 | $1.8M | +21.4% | — |
Insiders at Labcorp
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Adam H SchechterCEO, President | — | $8.4M | Aug 12, 2026 | — |
| Richelle P ParhamDirector | — | $1.8M | Feb 13, 2026 | — |
| Peter J WilkinsonSvp, Chief Accounting Officer | — | $1.1M | Aug 5, 2026 | — |
| Kerrii B AndersonDirector | — | $954K | Aug 18, 2026 | — |
| Brian J CaveneyEvp, Pres Of Ed, Cmo & Cso | — | $429K | Mar 30, 2026 | — |
| Jonathan C MeltzerEvp, Operations | — | $299K | Mar 30, 2026 | — |
| Amy B. SummyEvp, Chief Marketing Officer | — | $283K | Aug 6, 2026 | — |
| Kathryn W KyleGeneral Counsel | — | $227K | Jul 6, 2026 | — |
| Der Vaart Sandra D VanEvp, Corporate Affairs | — | $156K | Mar 30, 2026 | — |
| Bryan T VaughnPresident | — | $67K | Jul 6, 2026 | — |
| Mark S SchroederCOO | — | — | Mar 30, 2026 | — |
| Anita Z GrahamEvp, Chro | — | — | Mar 30, 2026 | — |
| Megan D. BaileyEvp, Pres, Central Labs & Intl | — | — | Mar 30, 2026 | — |
| Akinbolade OyegunwaCTO | — | — | Mar 30, 2026 | — |
| Julia Aijun WangCFO | — | — | Feb 13, 2026 | — |
| Jeffrey A. DavisDirector | — | — | Feb 13, 2026 | — |
| Kirsten Marie KliphouseDirector | — | — | Feb 13, 2026 | — |
| Garheng KongDirector | — | — | Feb 13, 2026 | — |
| Peter M NeupertDirector | — | — | Feb 13, 2026 | — |
| Kathryn E WengelDirector | — | — | Feb 13, 2026 | — |
| Paul RothmanDirector | — | — | Feb 13, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about LH insiders
Are Labcorp insiders buying LH stock?
In the past 12 months, 0 insiders reported open-market purchases of LH worth $0.
Are Labcorp insiders selling LH stock?
10 insiders reported sales worth $13.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.